News
MLAB
106.13
-1.35%
-1.45
Weekly Report: what happened at MLAB last week (0219-0223)?
Weekly Report · 2d ago
Weekly Report: what happened at MLAB last week (0212-0216)?
Weekly Report · 02/19 09:28
Weekly Report: what happened at MLAB last week (0205-0209)?
Weekly Report · 02/12 09:26
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mesa Laboratories, Inc. (NASDAQ:MLAB) reported its third-quarter results last week. The company's statutory earnings beat expectations by a notable 875%. The company is expected to report revenues of US$237.0m in 2025. However, analysts have downgraded their earnings per share estimates for the company. The consensus price target for Mesa Laboratories is now US$127.
Simply Wall St · 02/08 10:14
Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates
NASDAQ · 02/05 14:20
Mesa Laboratories Non-GAAP EPS of $2.02 beats by $0.32, revenue of $53.47M misses by $1.13M
Seeking Alpha · 02/05 13:03
Mesa Laboratories Q3 Adjusted EPS $2.02 May Not Be Comparable To $0.19 Estimate, Sales $53.47M Miss $54.89M Estimate
Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.02 per share. The company reported quarterly sales of $53.47 million. This is a 1.50 percent decrease over sales of the same period last year. Mesa Laboratories beat the analyst consensus estimate of $0.19 for the quarter.
Benzinga · 02/05 13:02
Earnings Scheduled For February 5, 2024
Companies Reporting Before The Bell: McDonald's is likely to report quarterly earnings at $2.82 per share on revenue of $6.45 billion. Caterpillar is projected to report earnings for its fourth quarter. Companies Reporting After The Bell include Bright Scholar Education and United States Steel.
Benzinga · 02/05 10:20
Weekly Report: what happened at MLAB last week (0129-0202)?
Weekly Report · 02/05 09:28
Earnings Preview: Mesa Laboratories
Mesa Laboratories is set to give its latest quarterly earnings report on Monday, 2024-02-05. Analysts estimate the company will report an earnings per share of $0.19. Last quarter the company beat EPS by $1.76. Shares of Mesa Laboratories were trading at $94.07 as of February 01.
Benzinga · 02/02 16:00
Weekly Report: what happened at MLAB last week (0122-0126)?
Weekly Report · 01/29 09:26
Andvari Associates Q4 2023 Letter
Seeking Alpha · 01/24 12:05
Mesa Laboratories: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 01/24 02:14
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.